Open AccessAnalgesic dose range finding of lornoxicam compared to diclofenac. Crossover double blind study in rheumatoid arthritis
Author(s) -
G Pasero,
Ombretta Di Munno
Publication year - 2011
Publication title -
reumatismo
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.294
H-Index - 25
eISSN - 2240-2683
pISSN - 0048-7449
DOI - 10.4081/reumatismo.2002.238
Subject(s) - medicine , lornoxicam , diclofenac , rheumatoid arthritis , analgesic , crossover study , piroxicam , arthritis , anesthesia , pharmacology , alternative medicine , pathology , placebo
To evaluate the therapeutic action and safety of lornoxicam, a new non steroidal anti-inflammatory drug, in 2 oral daily dose regimens of 8 and 16 mg in comparison with oral diclofenac 150 mg/day in patients with rheumatoid arthritis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom